New hope for Tough-to-Treat colon cancer?
Disease control
Terminated
This study tested whether adding an experimental drug called ompenaclid to standard chemotherapy could help control advanced colorectal cancer that had worsened after initial treatment. The trial involved 76 patients with a specific genetic mutation (RAS mutant) in their cancer. …
Phase: PHASE2 • Sponsor: Inspirna, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC